نتائج البحث - Susan Halabi

تنقيح النتائج
  1. 1
    Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology

    Developing and Validating Risk Assessment Models of Clinical Outcomes in Modern Oncology حسب Susan Halabi, Cai Li, Sheng Luo

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin

    Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin حسب Andrew J. Armstrong, Daniel J. George, Susan Halabi

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102 حسب George Philips, Susan Halabi, Ben L. Sanford, Dean F. Bajorin, Eric J. Small

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Cancer and Leukemia Group B 90206

    Cancer and Leukemia Group B 90206 حسب Brian I. Rini, Susan Halabi, John Taylor, Eric J. Small, Richard L. Schilsky

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer حسب Susan Halabi, Nicholas J. Vogelzang, San‐San Ou, Kouros Owzar, Laura Archer, Eric J. Small

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes

    Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes حسب Alyson Mahar, Carolyn C. Compton, Susan Halabi, Kenneth R. Hess, Martin R. Weiser, Patti A. Groome

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Breast cancer screening behaviors and attitudes in three racial/ethnic groups

    Breast cancer screening behaviors and attitudes in three racial/ethnic groups حسب Sally W. Vernon, Victor G. Vogel, Susan Halabi, Gilchrist L. Jackson, Ray O. Lundy, George N. Peters

    منشور في 1992
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Study

    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Stud... حسب Charles J. Ryan, Susan Halabi, San-San Ou, Nicholas J. Vogelzang, Philip W. Kantoff, Eric J. Small

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma

    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma حسب William Oh, Susan Halabi, William Kevin Kelly, Cary Werner, Paul A. Godley, Nicholas J. Vogelzang, Eric J. Small

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma

    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma حسب Nancy A. Dawson, Mark Conaway, Susan Halabi, Eric P. Winer, Eric J. Small, Diana Lake, Nicholas J. Vogelzang

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer

    Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer حسب Gillian Vandekerkhove, Veda N. Giri, Susan Halabi, Christopher McNair, Khaldoun Hamade, Rhonda L. Bitting, Alexander W. Wyatt

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Hormonal Risk Factors for Ovarian Cancer in Premenopausal and Postmenopausal Women

    Hormonal Risk Factors for Ovarian Cancer in Premenopausal and Postmenopausal Women حسب Patricia G. Moorman, Brian Calingaert, Rachel T. Palmieri, Edwin S. Iversen, Rex C. Bentley, Susan Halabi, Andrew Berchuck, Joellen M. Schildkraut

    منشور في 2008
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480

    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480 حسب Daniel J. George, Susan Halabi, Timothy F. Shepard, Ben L. Sanford, Nicholas J. Vogelzang, Eric J. Small, Philip W. Kantoff

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials

    Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials حسب Bernard F. Cole, Richard F. Logan, Susan Halabi, Robert Benamouzig, Robert S. Sandler, Matthew J. Grainge, Stanislas Chaussade, John A. Baron

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

    Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer حسب Andrew J. Armstrong, Mario A. Eisenberger, Susan Halabi, Stéphane Oudard, David M. Nanus, Daniel P. Petrylak, Oliver Sartor, Howard I. Scher

    منشور في 2011
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy حسب Susan Halabi, Andrew J. Armstrong, Oliver Sartor, Johann S. de Bono, Ellen B. Kaplan, Chen‐Yen Lin, Nicole Solomon, Eric J. Small

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer

    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer حسب Joel Picus, Susan Halabi, William Kevin Kelly, Nicholas J. Vogelzang, Young E. Whang, Ellen B. Kaplan, Walter M. Stadler, Eric J. Small

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer حسب Susan Halabi, Chen‐Yen Lin, William K. Kelly, Karim Fizazi, Judd W. Moul, Ellen B. Kaplan, Michael J. Morris, Eric J. Small

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas

    Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas حسب Sangmi Kim, Temitope O. Keku, Christopher F. Martin, Joseph A. Galanko, John T. Woosley, Jane C. Schroeder, Jessie A. Satia, Susan Halabi, Robert S. Sandler

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia

    Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia حسب C. Patrick Burns, Susan Halabi, Gerald H. Clamon, Ellen B. Kaplan, Raymond J. Hohl, James N. Atkins, Michael Schwartz, Brett A. Wagner, Electra Paskett

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: